Page last updated: 2024-11-05

octyltrimethylammonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

octyltrimethylammonium: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

octyltrimethylammonium ion : A quarternary ammonium cation having one octyl and three methyl substituents around the central nitrogen. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24950
CHEMBL ID1180979
CHEBI ID55321
SCHEMBL ID240380
MeSH IDM0124311

Synonyms (18)

Synonym
octyltrimethylammonium
trimethyl(octyl)azanium
trimethyloctylammonium ion
octyltrimethylammonium cation
octyltrimethylammonium ion
n,n,n-trimethyl-1-octanaminium
15461-38-8
n,n,n-trimethyloctan-1-aminium
CHEBI:55321 ,
trimethyl-n-octylammonium
trimethyloctylammonium
1-octanaminium, n,n,n-trimethyl-
CHEMBL1180979
SCHEMBL240380
HTKPDYSCAPSXIR-UHFFFAOYSA-N
DTXSID10165674
[1-(4-amino-phenyl)-pyrrolidin-3-yl]-carbamicacidtert-butylester
Q27124227
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
quaternary ammonium ionA derivative of ammonium, NH4(+), in which all four of the hydrogens bonded to nitrogen have been replaced with univalent (usually organyl) groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.76)18.7374
1990's2 (11.76)18.2507
2000's6 (35.29)29.6817
2010's5 (29.41)24.3611
2020's2 (11.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]